{"id":"NCT01713530","sponsor":"Novo Nordisk A/S","briefTitle":"A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin","officialTitle":"A 26-week Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart BID and Insulin Degludec OD Plus Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin in Need of Treatment Intensification With Mealtime Insulin","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02-21","primaryCompletion":"2014-01-09","completion":"2014-01-09","firstPosted":"2012-10-24","resultsPosted":"2015-11-17","lastUpdate":"2018-04-02"},"enrollment":274,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Diabetes Mellitus, Type 2"],"interventions":[{"type":"DRUG","name":"insulin degludec/insulin aspart","otherNames":[]},{"type":"DRUG","name":"insulin degludec","otherNames":[]},{"type":"DRUG","name":"insulin aspart","otherNames":[]}],"arms":[{"label":"IDegAsp BID+/-OADs","type":"EXPERIMENTAL"},{"label":"IDeg OD plus IAsp +/-OADs","type":"EXPERIMENTAL"}],"summary":"This trial is conducted in Africa, Europe and the United States of America (USA).\n\nThe aim of the trial is to compare the difference in change in glycosylated haemoglobin (HbA1c) between insulin degludec/insulin aspart (IDegAsp) and/or oral anti-diabetic drugs (OADs) and insulin degludec (IDeg) plus insulin aspart (IAsp)and/or OADs.","primaryOutcome":{"measure":"Change From Baseline in HbA1c (%)","timeFrame":"Week 0, week 26","effectByArm":[{"arm":"IDegAsp BID","deltaMin":-1.23,"sd":0.13},{"arm":"IDeg OD+IAsp","deltaMin":-1.42,"sd":0.12}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":51,"countries":["United States","Algeria","Austria","France","Norway"]},"refs":{"pmids":["26592732","29451706","35044568"],"seeAlso":["http://novonordisk-trials.com"]},"adverseEventsSummary":{"seriousAny":{"events":7,"n":136},"commonTop":["Nasopharyngitis","Diarrhoea","Headache","Influenza","Asthenia"]}}